apc conjugated anti-mouse ly6c (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
apc conjugated anti-mouse ly6c
Apc Conjugated Anti Mouse Ly6c, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apc+conjugated+anti-mouse+ly6c/anti+gr+1/pmc12185437-105-27-59
Average 90 stars, based on 1 article reviews
Apc Conjugated Anti Mouse Ly6c, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apc+conjugated+anti-mouse+ly6c/anti+gr+1/pmc12185437-105-27-59
Average 90 stars, based on 1 article reviews
apc conjugated anti-mouse ly6c - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "Modeling pathogen-driven neonatal late-onset sepsis: a modification to the murine cecal slurry"
Article Title: Modeling pathogen-driven neonatal late-onset sepsis: a modification to the murine cecal slurry
Journal: Frontiers in Cellular and Infection Microbiology
doi: 10.3389/fcimb.2025.1589712
Figure Legend Snippet: Characterization of pathologic slurry induced sepsis on the relative abundance of leukocytes in the lamina propria and spleen. Four hours following injection, mice were euthanized and single cell suspensions of leukocytes from lamina propria and spleens were processed for flow cytometry as described in methods. (A) Representative gating strategy: Single cell leukocytes were first gated by CD3 and CD19. Among CD3+, CD19- cells, CD4 helper T-cells were defined as CD4+, CD8- and CD8 cytotoxic T cells were defined as CD8+, CD4-. Regulatory T cells were identified as CD4+, CD25+. B cells were defined as CD19+, CD3-. Among CD3-,CD19- cells, Natural Killer cells were defined as NK1.1+, Dendritic cells as MHCII+, CD11c+, Neutrophils as Ly6G+, CD11b+, macrophages as F4/80+, CD11b+ and monocytes as MHCII low , Ly6C+. The relative expression of leukocyte populations within the (B) Lamina Propria (LP) and (C) Spleen was compared between control mice and sepsis exposed mice. Comparisons were made by unpaired T tests. Bars represent the mean values with error bars representing the standard error of the mean. Control LP (N = 12), Sepsis LP (N = 9), Control Spleen (N = 12), Sepsis Spleen (N = 10), significance noted as *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Techniques Used: Injection, Flow Cytometry, Expressing, Control
Related Articles
Staining:Article Title: Modeling pathogen-driven neonatal late-onset sepsis: a modification to the murine cecal slurry Article Snippet: The following antibodies were used for staining: PE-Cy7 conjugated anti-mouse CD3, PE conjugated anti-mouse CD4, FITC conjugated anti-mouse CD8, PE conjugated anti-mouse CD11b, FITC conjugated anti-mouse CD11c, PE-efluor 610 conjugated anti-mouse CD25, APC conjugated anti-mouse Ly6C, PE-Cyanine5 conjugated anti-mouse Ly6G, Alexa Fluor 700 conjugated anti-mouse MHC Class II, Brillian Violet 605 conjugated anti-mouse NK1.1, Immunopeptidomics:Article Title: Modeling pathogen-driven neonatal late-onset sepsis: a modification to the murine cecal slurry Article Snippet: The following antibodies were used for staining: PE-Cy7 conjugated anti-mouse CD3, PE conjugated anti-mouse CD4, FITC conjugated anti-mouse CD8, PE conjugated anti-mouse CD11b, FITC conjugated anti-mouse CD11c, PE-efluor 610 conjugated anti-mouse CD25, APC conjugated anti-mouse Ly6C, PE-Cyanine5 conjugated anti-mouse Ly6G, Alexa Fluor 700 conjugated anti-mouse MHC Class II, Brillian Violet 605 conjugated anti-mouse NK1.1, Injection:Article Title: Modeling pathogen-driven neonatal late-onset sepsis: a modification to the murine cecal slurry Article Snippet: The following antibodies were used for staining: PE-Cy7 conjugated anti-mouse CD3, PE conjugated anti-mouse CD4, FITC conjugated anti-mouse CD8, PE conjugated anti-mouse CD11b, FITC conjugated anti-mouse CD11c, PE-efluor 610 conjugated anti-mouse CD25, APC conjugated anti-mouse Ly6C, PE-Cyanine5 conjugated anti-mouse Ly6G, Alexa Fluor 700 conjugated anti-mouse MHC Class II, Brillian Violet 605 conjugated anti-mouse NK1.1, Flow Cytometry:Article Title: Modeling pathogen-driven neonatal late-onset sepsis: a modification to the murine cecal slurry Article Snippet: The following antibodies were used for staining: PE-Cy7 conjugated anti-mouse CD3, PE conjugated anti-mouse CD4, FITC conjugated anti-mouse CD8, PE conjugated anti-mouse CD11b, FITC conjugated anti-mouse CD11c, PE-efluor 610 conjugated anti-mouse CD25, APC conjugated anti-mouse Ly6C, PE-Cyanine5 conjugated anti-mouse Ly6G, Alexa Fluor 700 conjugated anti-mouse MHC Class II, Brillian Violet 605 conjugated anti-mouse NK1.1, Expressing:Article Title: Modeling pathogen-driven neonatal late-onset sepsis: a modification to the murine cecal slurry Article Snippet: The following antibodies were used for staining: PE-Cy7 conjugated anti-mouse CD3, PE conjugated anti-mouse CD4, FITC conjugated anti-mouse CD8, PE conjugated anti-mouse CD11b, FITC conjugated anti-mouse CD11c, PE-efluor 610 conjugated anti-mouse CD25, APC conjugated anti-mouse Ly6C, PE-Cyanine5 conjugated anti-mouse Ly6G, Alexa Fluor 700 conjugated anti-mouse MHC Class II, Brillian Violet 605 conjugated anti-mouse NK1.1, Control:Article Title: Modeling pathogen-driven neonatal late-onset sepsis: a modification to the murine cecal slurry Article Snippet: The following antibodies were used for staining: PE-Cy7 conjugated anti-mouse CD3, PE conjugated anti-mouse CD4, FITC conjugated anti-mouse CD8, PE conjugated anti-mouse CD11b, FITC conjugated anti-mouse CD11c, PE-efluor 610 conjugated anti-mouse CD25, APC conjugated anti-mouse Ly6C, PE-Cyanine5 conjugated anti-mouse Ly6G, Alexa Fluor 700 conjugated anti-mouse MHC Class II, Brillian Violet 605 conjugated anti-mouse NK1.1, |